Skip to main content
Log in

Diagnosis of ductal carcinoma in situ (DCIS) and intraductal papilloma using fluorescence in Situ Hybridization (FISH) analysis

  • Panel Discussion II
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Background

It is often difficult to pre-operatively diagnose ductal carcinoma in situ (DCIS) or intraductal papilloma (IDP). Current reports show that breast cancer frequently has numerical aberrations of chromosomes 1, 11 and 17. We investigated whether fluorescence in situ hybridization (FISH) analysis using three centromere-specific probes for chromosomes 1, 11 and 17 was fesible for diagnosing intraductal breast lesions.

Methods

Fine-needle aspiration specimens from 102 breast lesions including DCIS (10), invasive ductal carcinoma (IDC) (78), IDP (7), fibroadenoma (6) and mastopathy (1) were examined for numerical aberrations on chromosomes 1, 11, 17 using FISH. If over 15% of all cells showed one signal, the sample was judged monosomic. If over 20% of cells showed three or more signals, it was considered polysomic. If the specimen had an aberration of at least one chromosome, it was judged positive.

Result

Nine of 10 DCISs showed numerical aberrations of at least one chromosome whereas 65 of 78 IDCs and 2 of 14 benign lesions (containing 7 IDPs of which one case was positive) showed numerical aberrations on these chromosomes. The proportion of positive results was highest with DCIS. Moreover 6 out of 7 DCISs showed an aberration of all three chromosomes simultaneously and one case showed an aberration of two chromosomes. All aberrations in case of DCIS were polysomic while two benign lesions and 15 IDCs showed a monosomic pattern.

Conclusion

FISH may enable more accurate diagnosis of intraductal breast lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

DCIS:

Ductal carcinomain situ

IDP:

Intraductal papilloma

FISH:

Fluorescence insitu hybridization

FNA:

Fine needle aspiration biopsy

LOH:

Loss of heterozygosity

References

  1. Gebhart E, Bruderlein S, Augustus M,et al: Cytogenetic studies on human breast carcinomas.Breast Cancer Res Treat 8:125–138, 1986.

    Article  PubMed  CAS  Google Scholar 

  2. Pandis N, Jin Y, Gorunova L,et al: Chromosome analysis of 97 primary breast carcinomas: identification of eight karyotypic subgroups.Genes Chromosom Cancer 12:173–185, 1995.

    Article  PubMed  CAS  Google Scholar 

  3. Persons DL, Robinson RA, Hsu PH,et al: Chromosome-specific aneusomy in carcinoma of the breast.Clni Cancer Res 2:883–888, 1996.

    CAS  Google Scholar 

  4. Fiegl M, Kaufmann H, Zojer N,et al: Malignant cell detection by fluorescence in situ hybridization (FISH) in effusions from patients with carcinom.Hum Pathol 31:448–455, 2000.

    Article  PubMed  CAS  Google Scholar 

  5. Tsuda H, Takarabe T, Susumu N,et al: Detection of numerical and structural Alterations and fusion of chromosomes 16 and 1 in low-grade papillary breast carcinoma by fluorescence in situ hybridization.Am J Pathol 151:1027–1034, 1997.

    PubMed  CAS  Google Scholar 

  6. Kokalj-Vokac N, Alemedia A, Gerbault-Seureau M,et al: Two-color FISH characterization of i (lq), and der (1;16) in human breast cancer cells.Genes Chromosom Cancer 7:8–14, 1993.

    Article  PubMed  CAS  Google Scholar 

  7. Anderson TI, Gaustad A, Ottestad L,et al: Genetic alterations of the tumor suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas.Genes Chromosom Cancer 4:113–121, 1992.

    Article  Google Scholar 

  8. Bieche I, Champeme MH, Mtifas F,et al: Two distinct regions involved lp deletion in human primary breast cancer.Cancer Res 53:4486–4488, 1993.

    Google Scholar 

  9. Walker RA, Dealing SJ, Lane DR,et al: Expression of p53 protein in infiltrating and in-situ breast carcinoma.J Pathol 165:203–211, 1991.

    Article  PubMed  CAS  Google Scholar 

  10. Nassiri M, Nadji M, Fresno M,et al: Bcl-2 is expressed minly in estrogen receptor-positive, p53-negative breast cancer.Proc Am Assoc Canc Res 36:622, 1995.

    Google Scholar 

  11. Ichikawa D, Hashimoto N, Hoshima M,et al: Analysis of numerical aberrations in specific chromo somes by fluorescent in situ hybridization as a diagnostic tool in breast cancer.Cancer 77:2064–2069, 1996.

    Article  PubMed  CAS  Google Scholar 

  12. Kline T, Joshi L, Neal H: Fine needle aspiration of the breast: diagnosis and pitfaals.Cancer 44:1458–1464, 1979.

    Article  PubMed  CAS  Google Scholar 

  13. Mendelin J, Grayson M, Wallis T,et al: Analysis of chromosome aneuploidy in breast carcinoma progression by using fluorescence in situ hybridization.Lab Invest 79:387–393, 1999.

    PubMed  CAS  Google Scholar 

  14. Marinho AF, Botelho M, Schmittn FC: Evaluation of numerical abnormalities of chromosomes 1 and 17 in proliferative epithelial breast lesions using fluorescence in situ hybridization.Pathol Res Pract 196:227–233, 2000.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Komoike, Y., Motomura, K., Inaji, H. et al. Diagnosis of ductal carcinoma in situ (DCIS) and intraductal papilloma using fluorescence in Situ Hybridization (FISH) analysis. Breast Cancer 7, 332–336 (2000). https://doi.org/10.1007/BF02966400

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02966400

Key words

Navigation